Most Recent Discussions

Jun 26 2009

Re: Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study

In reading the details found within the journal article highlighted above, it is evident that significant efforts must be made to educate the population better as to the risks of glaucoma and the need for regular eye evaluations. The
read more

 

Apr 03 2008

Re: Oxidative Stress in Glaucoma: A Burden of Evidence

This article manifests some interesting insight. So far, we have failed to address the fundamental question: Why (among the one million densely packed nerve fibers in a 1.5 mm sized optic disc) only the peripheral fibers are selectively destroyed first
read more

 

Aug 21 2007

Re: Interesting Glaucoma Cases

Hello, This has been an interesting discussion with many valid points made. I would like to add two observations. The concurrent use of Pilo and a prostaglandin is unusual as these modalities don't synergize well, as their modes of action are
read more

 
 

Clinician Topics

Glaucoma Watch
Interesting Glaucoma Cases
From Ocular Hypertension to Glaucoma: How to Predict Conversion
Neckties and IOP: The Controversy Continues
Introduction to the National Glaucoma Society
Case Presentation: Optic Nerve Imaging
NGS Residency Award and Lecture
Optic Nerve Head Measurements with the HRT III
Case Presentation: Laser Imaging Detects Early ON Damage
Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
Interview with Dr. Barry Barresi
NGS to Offer Webinars
Glaucoma Continuum
Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study
The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
Oxidative Stress in Glaucoma: A Burden of Evidence
Gonioscopy Videos
Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women
In Your Office
Glaucoma Flowsheet
Tonometer Calibration
Pachymetry Coding
BCBS Coverage of SCODI Services
Expanded Coverage of Glaucoma Screening Services
Pharmacology Update
Extravan: Alcon Pharmaceuticals
Mechanism of IOP Reduction with Travoprost
Clinical Guidelines
CCT: Is is time to say YES?
The Role of CCT in Glaucoma Patients
More CCT
The Paradox of IOP
Should We Treat All Ocular Hypertensives?
Beta Blockers in Glaucoma Management
Re-Defining Ocular Hypertension
Implications of Macro-Disc Asymmetry in Glaucoma Suspects
Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
Industry News
New FDA Approval for Lumigan
Alcon's Travatan Z Solution Receives FDA Approval
Alcon's Travatan Z and Systane Use Different Preservatives
Pfizer Sponsors New "All Eyes on Glaucoma" Website
 
TravatanZ      Allergan
Optoview      Pfizer Opthalmics      CZmeditec      Ziermer